Patients
ONCOLOGY, DISEASE
Patients were enrolled into the following treatment cohorts (Key inclusion criteria included previous diagnosis of MM with objective evidence of measurable disease and an Eastern Cooperative Oncology Group performance status (ECOG PS) of ≤2 (The study was conducted in accordance with the International Conference on Harmonization guidelines for Good Clinical Practice, and the protocol was approved by the ethics committees of all participating centers and registered at ClinicalTrials.gov (NCT02431208). All patients provided written informed consent.